Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Safety and tolerability of three different concentrations (0.1%, 03%, 0.6%) of the investigational SHP639 eye drops will be evaluated in participants with high eye pressure or primary open-angle glaucoma.
Epistemonikos ID: 7cdd42bdc1e8928cc0ea3b6bda62f8c8778d5ba1
First added on: May 20, 2024